Taylor Devices, Inc. filings document governance, compensation and shareholder-vote matters for the Nasdaq-listed manufacturer of shock absorption, rate control and energy storage devices. The definitive proxy statement describes annual meeting proposals, including director election matters, auditor ratification and the 2025 Taylor Devices, Inc. Stock Option Plan.
Form 8-K disclosures report material events such as shareholder voting results and approval of compensatory arrangements. Together, the filings record board election mechanics, independent auditor matters, equity incentive-plan governance and related public-company reporting obligations.
Taylor Devices, Inc. (TAYD) shareholders approved all three management proposals at the October 16, 2026 annual meeting. Timothy J. Sopko was elected as a Class 2 director for a three-year term expiring in 2029, with 1,671,112 votes for and 151,303 withheld; there were 569,777 broker non-votes.
Shareholders ratified Lumsden & McCormick, LLP as the independent registered public accounting firm for the fiscal year ending May 31, 2027. They also approved named executive officer compensation on a non-binding, advisory basis, with 1,720,222 votes for, 82,386 against and 19,807 abstentions.
Taylor Devices, Inc. (TAYD) director John Burgess exercised options on October 2, 2026, to acquire 5,000 common shares at an exercise price of $13.80 per share. The reported exercise paired a disposition of 5,000 options with acquisition of 5,000 shares; his directly held common-stock position afterward was 48,426 shares.
Taylor Devices, Inc. (TAYD) reported lower sales and earnings for the three months ended August 31, 2026. Net sales were $7,300,000, down 26% from $9,918,000 a year earlier; management attributed the decline to booking and backlog-conversion timing. Net income fell 79% to $456,933 from $2,190,084, and basic and diluted earnings per share were $0.14 versus $0.70. Gross profit was 30% of sales compared with 45%, while operating income was $38,454, down 98.3% from $2,245,267.
At August 31, 2026, backlog was $55.2 million across 151 open orders, versus $27.9 million across 127 orders as of August 31, 2025; it included a $19.0 million non-project order. Taylor Devices expects to recognize most remaining backlog revenue in the current fiscal year and the balance in the fiscal year ending May 31, 2028. Net cash from operating activities was $7,786,539, compared with $483,628 a year earlier. Cash and cash equivalents were $3,600,212, and short-term investments were $45,478,228. Capital expenditure commitments totaled $1,928,000 for the next 12 months.
Taylor Devices, Inc. (TAYD) is asking shareholders at the October 16, 2026 in-person annual meeting to elect CEO Timothy J. Sopko as a Class 2 director through 2029, ratify Lumsden & McCormick, LLP as auditor for the year ending May 31, 2027, and approve an advisory say‑on‑pay resolution for named executive officers.
Shareholders of record at the close of business on August 17, 2026, when 3,225,365 shares of common stock were outstanding and entitled to one vote each, may vote in person or by proxy. The proxy details board composition and independence, committee activity, director and executive compensation, equity plans, major shareholders, indemnification arrangements, and auditor fees and approval policies.
Taylor Devices, Inc. designs and manufactures shock absorption and energy storage products, with major exposure to aerospace/defense and structural (seismic) markets. For the year ended May 31, 2026, the company reported net revenue of $41.6 million, down 10% from $46.3 million, and net income of $8.6 million, down $0.8 million.
Gross profit was $18.3 million with a 44% margin, two points lower than 2025. Structural sales fell 31%, while aerospace/defense grew 1% and industrial declined 11%. U.S. sales rose as a share of total to 87%, while Asia dropped to 8% of revenue.
Despite lower revenue, Taylor Devices ended the year with a strong balance sheet, including $40.6 million in short-term investments, $0.9 million in cash, no borrowings on a $10 million credit line, and total stockholders’ equity of $72.9 million. Backlog increased sharply to $52.8 million from $27.1 million, heavily weighted (92%) to aerospace/defense, and includes a $19.0 million non-project order extending through fiscal 2030. R&D spending rose 75% to $776,000, while SG&A declined 10% to $10.2 million. The effective tax rate dropped to 5%, aided by research credits and share-based payment effects. Management and auditors both concluded internal control over financial reporting is effective.
Vanguard Capital Management, together with specified affiliates, reports beneficial ownership of common stock of Taylor Devices Inc. The group holds 166,333 shares, representing 5.16% of the class as of June 30, 2026.
Vanguard Capital Management has sole voting power over 21,447 shares and sole dispositive power over 166,333 shares, with no shared voting or dispositive power. The filing explains that these holdings include securities held by Vanguard funds and managed accounts over which the reporting entities exercise voting and/or dispositive power, and notes that no other single person has more than a 5% interest in the reported securities.
BlackRock, Inc. has reported beneficial ownership of common stock of Taylor Devices, Inc. on a Schedule 13G. BlackRock and certain of its subsidiaries and affiliates beneficially own 177,884 shares of Taylor Devices common stock, representing 5.5% of the class.
BlackRock reports sole voting power over 175,070 shares and sole dispositive power over 177,884 shares, with no shared voting or dispositive power. Various underlying clients have rights to dividends or sale proceeds from these shares, but no single such person has more than five percent of Taylor Devices’ outstanding common shares.
Taylor Devices, Inc. director Robert Michael Carey reported selling a total of 5,000 shares of Common Stock in open-market transactions. On April 28, 2026, he executed two separate sales at weighted average prices of $57.27 and $55.52 per share.
Footnotes explain that each reported price is a weighted average for multiple trades completed within narrow ranges around those prices, and that detailed price-by-trade information is available upon request. The transactions were reported as direct ownership sales.
TAYD submitted a Form 144 notice regarding the proposed sale of Common shares. The filing lists a quantity of 5,000 and an associated numeric value of 285,600.00, references Nasdaq, and records two prior option exercises dated 10/28/2024 that converted 3,989 and 3,732 shares from equity compensation awards dated 04/18/2022 and 04/22/2021.